7817 Stock Overview
Paramount Bed Holdings Co., Ltd. manufactures and sells beds, mattresses, and equipment for medical and nursing care in Japan.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Paramount Bed Holdings Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥2,649.00 |
52 Week High | JP¥2,870.00 |
52 Week Low | JP¥2,173.00 |
Beta | 0.15 |
1 Month Change | 1.46% |
3 Month Change | -2.00% |
1 Year Change | 12.48% |
3 Year Change | 20.85% |
5 Year Change | 4.09% |
Change since IPO | 23.38% |
Recent News & Updates
Shareholder Returns
7817 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | -5.0% | 0.5% | -2.2% |
1Y | 12.5% | 10.2% | 29.7% |
Return vs Industry: 7817 exceeded the JP Medical Equipment industry which returned 10.2% over the past year.
Return vs Market: 7817 underperformed the JP Market which returned 29.7% over the past year.
Price Volatility
7817 volatility | |
---|---|
7817 Average Weekly Movement | 2.9% |
Medical Equipment Industry Average Movement | 3.9% |
Market Average Movement | 4.0% |
10% most volatile stocks in JP Market | 8.3% |
10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 7817 has not had significant price volatility in the past 3 months.
Volatility Over Time: 7817's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1947 | 3,946 | Tomohiko Kimura | www.paramountbed-hd.co.jp |
Paramount Bed Holdings Co., Ltd. manufactures and sells beds, mattresses, and equipment for medical and nursing care in Japan. It also engages in the inspection and maintenance of Paramount bed products; and leasing and wholesale of welfare care products. The company was founded in 1947 and is headquartered in Tokyo, Japan.
Paramount Bed Holdings Co., Ltd. Fundamentals Summary
7817 fundamental statistics | |
---|---|
Market cap | JP¥157.50b |
Earnings (TTM) | JP¥9.14b |
Revenue (TTM) | JP¥100.96b |
16.6x
P/E Ratio1.5x
P/S RatioIs 7817 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
7817 income statement (TTM) | |
---|---|
Revenue | JP¥100.96b |
Cost of Revenue | JP¥52.50b |
Gross Profit | JP¥48.46b |
Other Expenses | JP¥39.32b |
Earnings | JP¥9.14b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
Earnings per share (EPS) | 159.19 |
Gross Margin | 48.00% |
Net Profit Margin | 9.05% |
Debt/Equity Ratio | 0% |
How did 7817 perform over the long term?
See historical performance and comparison